Structures by: Uekusa H.
Total: 300
C38H26O2
C38H26O2
Organic letters (2017) 19, 1 42-45
a=15.308(3)Å b=18.011(4)Å c=18.454(4)Å
α=90.00(3)° β=90.22(3)° γ=90.00(3)°
1
C40H26O6
Organic letters (2017) 19, 1 42-45
a=7.6621(10)Å b=9.8166(11)Å c=19.265(2)Å
α=90° β=101.448(7)° γ=90°
C31H36ClNO10
C31H36ClNO10
Organic letters (2016) 18, 9 2170-2173
a=8.8859(2)Å b=26.1897(5)Å c=13.3329(2)Å
α=90° β=91.4160(10)° γ=90°
YA375-F1
C29H22O4
Organic letters (2016) 18, 11 2672-2675
a=5.1050(1)Å b=9.9850(2)Å c=11.8359(2)Å
α=65.909(1)° β=85.150(1)° γ=82.591(1)°
C44H40B4N4O8S2,C14H10,CH2Cl2
C44H40B4N4O8S2,C14H10,CH2Cl2
Chem. Sci. (2016) 7, 9 5765
a=18.5357(5)Å b=20.6392(10)Å c=14.1552(7)Å
α=90.00° β=90.00° γ=90.00°
C44H40B4N4O8S2,C14H10,4(CHCl3)
C44H40B4N4O8S2,C14H10,4(CHCl3)
Chem. Sci. (2016) 7, 9 5765
a=10.54186(19)Å b=12.9408(2)Å c=14.3073(3)Å
α=69.8702(7)° β=73.6990(7)° γ=79.7710(7)°
C44H40B4N4O8S2,5(CHCl3)
C44H40B4N4O8S2,5(CHCl3)
Chem. Sci. (2016) 7, 9 5765
a=13.7207(3)Å b=14.0837(3)Å c=20.4986(3)Å
α=90° β=122.8400(10)° γ=90°
C56H50B4Cl12N4O8S3
C56H50B4Cl12N4O8S3
Chem. Sci. (2016) 7, 9 5765
a=13.6699(7)Å b=14.0308(9)Å c=20.6325(9)Å
α=90.00° β=122.572(3)° γ=90.00°
C44H40B4N4O8S2,C8H6O,4(CHCl3)
C44H40B4N4O8S2,C8H6O,4(CHCl3)
Chem. Sci. (2016) 7, 9 5765
a=13.6823(12)Å b=14.0543(13)Å c=20.5851(14)Å
α=90.00° β=122.711(4)° γ=90.00°
C57H51B4Cl12N5O8S2
C57H51B4Cl12N5O8S2
Chem. Sci. (2016) 7, 9 5765
a=13.6829(10)Å b=14.0362(10)Å c=20.6735(11)Å
α=90.00° β=122.667(3)° γ=90.00°
C44H40B4N4O8S2,C10H8,2(CHCl3)
C44H40B4N4O8S2,C10H8,2(CHCl3)
Chem. Sci. (2016) 7, 9 5765
a=13.7340(6)Å b=14.1169(5)Å c=20.8001(7)Å
α=90° β=122.833(2)° γ=90°
Ring
C94.67H110.34O17.84
Organic Letters (2017)
a=27.6554(5)Å b=26.5185(5)Å c=26.1889(5)Å
α=90° β=94.4140(10)° γ=90°
Au_G
C18H4Au2F8N4
Chem. Sci. (2015) 6, 4 2187
a=3.5707(3)Å b=10.3087(10)Å c=14.2742(11)Å
α=107.689(4)° β=92.505(5)° γ=100.205(5)°
Au_Y
C18H4Au2F8N4
Chem. Sci. (2015) 6, 4 2187
a=7.79058(18)Å b=18.7202(5)Å c=6.74157(17)Å
α=90.0° β=103.1674(33)° γ=90.0°
RH2927-2
C28H22B2N2O3,C4H8O2
Organic letters (2014) 16, 23 6240
a=17.2259(3)Å b=19.4533(4)Å c=25.7366(5)Å
α=90° β=103.1610(10)° γ=90°
RH2Y15-1
C18H11BO2
Organic letters (2014) 16, 23 6240
a=5.16120(10)Å b=15.5151(3)Å c=15.9033(3)Å
α=90° β=91.2140(10)° γ=90°
C41H46N2O15
C41H46N2O15
Organic Letters (2013) 15, 9 2076
a=10.5602(5)Å b=10.4546(4)Å c=37.7085(15)Å
α=90.00° β=95.612(2)° γ=90.00°
Acrinol anhydrous form I
C15H16N3O,C3H5O3
The Journal of Physical Chemistry C (2010) 114, 1 580
a=8.04668(25)Å b=9.35578(20)Å c=11.91507(22)Å
α=102.4356(19)° β=103.1773(31)° γ=98.6481(25)°
Acrinol anhydrous form II
C15H16N3O,C3H5O3
The Journal of Physical Chemistry C (2010) 114, 1 580
a=14.0496(5)Å b=11.80399(19)Å c=20.9323(8)Å
α=90.0° β=100.9361(33)° γ=90.0°
5,5'-di-tert-butyl-2,2'-bis-p-benzoquinone
C20H22O4
Organic letters (2007) 9, 26 5417-5420
a=10.392(2)Å b=6.462(2)Å c=13.048(2)Å
α=90.00° β=94.84(2)° γ=90.00°
C14H20O2
C14H20O2
Organic letters (2007) 9, 26 5417-5420
a=6.7308(8)Å b=10.0398(12)Å c=10.0115(12)Å
α=90.00° β=92.660(2)° γ=90.00°
CMI gallate
C12H12ClNO6S
Analytical Sciences: X-ray Structure Analysis Online (2003) 19, x47-x48
a=12.402(2)Å b=10.257(2)Å c=11.295(3)Å
α=90.00° β=96.856(10)° γ=90.00°
5-chloro-2-methyl-4-isothiazoline-3-one and 4,4'-ethylidenebisphenol
C18H18ClNO3S
Analytical Sciences: X-ray Structure Analysis Online (2003) 19, x45-x46
a=16.152(6)Å b=10.127(5)Å c=11.450(5)Å
α=90.00° β=105.48(3)° γ=90.00°
Scorbamic acid
C6H9NO5
Analytical Sciences: X-ray Structure Analysis Online (2003) 19, x65-x66
a=8.8162(6)Å b=16.9420(15)Å c=4.8651(3)Å
α=90.00° β=90.00° γ=90.00°
Erythroscorbamic acid
C6H9NO5
Analytical Sciences: X-ray Structure Analysis Online (2003) 19, x65-x66
a=8.3338(13)Å b=10.294(2)Å c=8.029(2)Å
α=90.00° β=90.00° γ=90.00°
Ciprofloxacin Hydrochloride 1.43 Hydrate
C17H19FN3O3,0.215(H4O2),Cl,H2O
CrystEngComm (2020)
a=7.02521(13)Å b=19.6681(4)Å c=12.9331(2)Å
α=90° β=90.7338(7)° γ=90°
Ciprfloxacin Hydrochloride Anhydrous Form I
C17H19FN3O3,Cl
CrystEngComm (2020)
a=18.1041(6)Å b=7.30090(17)Å c=26.2525(10)Å
α=90.0° β=90.0° γ=90.0°
Cyasterone 1
C32H56O11
Organic & biomolecular chemistry (2005) 3, 7 1227-1232
a=13.6542(11)Å b=7.7755(4)Å c=15.7636(12)Å
α=90.00° β=100.215(3)° γ=90.00°
28-epi-cyasterone 2
C29H50O11
Organic & biomolecular chemistry (2005) 3, 7 1227-1232
a=13.3374(17)Å b=7.6406(10)Å c=15.5158(19)Å
α=90.00° β=98.311(4)° γ=90.00°
C26H26B2FeO4
C26H26B2FeO4
Dalton transactions (Cambridge, England : 2003) (2017) 46, 7 2370-2376
a=10.6429(5)Å b=15.1158(10)Å c=7.5906(4)Å
α=100.4774(35)° β=99.7785(18)° γ=107.4466(20)°
C52H52B4Fe2O8,(CHCl3)2
C52H52B4Fe2O8,(CHCl3)2
Dalton transactions (Cambridge, England : 2003) (2017) 46, 7 2370-2376
a=11.5229(6)Å b=14.4999(8)Å c=18.9095(11)Å
α=65.3670(10)° β=70.676(2)° γ=83.183(2)°
C72H72B4Fe4O8
C72H72B4Fe4O8
Dalton transactions (Cambridge, England : 2003) (2017) 46, 7 2370-2376
a=13.2454(5)Å b=20.5430(8)Å c=22.8531(9)Å
α=90° β=90° γ=90°
C70H56
C70H56
Chemical communications (Cambridge, England) (2020) 56, 95 14988-14991
a=8.80384(16)Å b=9.18711(17)Å c=30.3074(6)Å
α=90° β=96.5951(10)° γ=90°
Anti-5-[2-(4-trifluoromethylphenyl)isoindoline-1,3-dionyl]methyl dispiro[tricyclo [3.3.1.13,7]decane-2,3'-[1,2]dioxetane-4',2''-tricyclo[3.3.1.13,7]decan]-5-carboxylate
C37H36F3NO6
Chemical communications (Cambridge, England) (2020) 56, 23 3369-3372
a=6.4039(4)Å b=49.826(3)Å c=9.4014(5)Å
α=90° β=90.163(2)° γ=90°
Syn-5-[2-(4-trifluoromethylphenyl)isoindoline-1,3-dionyl]methyl dispiro[tricyclo [3.3.1.13,7]decane-2,3'-[1,2]dioxetane-4',2''-tricyclo[3.3.1.13,7]decan]-5-carboxylate
C37H36F3NO6
Chemical communications (Cambridge, England) (2020) 56, 23 3369-3372
a=6.847(2)Å b=9.989(3)Å c=23.661(8)Å
α=81.861(13)° β=81.721(11)° γ=71.02(2)°
4Br4Ph
C46H26Br4
Journal of Materials Chemistry C (2019) 7, 11 3294
a=10.3811(3)Å b=13.2135(4)Å c=13.8306(4)Å
α=81.924(2)° β=77.158(2)° γ=72.986(2)°
4Cl4Ph
C46H26Cl4
Journal of Materials Chemistry C (2019) 7, 11 3294
a=10.3770(13)Å b=12.874(2)Å c=13.3509(17)Å
α=86.033(6)° β=77.911(4)° γ=74.579(5)°
4F4Ph
C46H26F4
Journal of Materials Chemistry C (2019) 7, 11 3294
a=10.0390(2)Å b=13.0700(2)Å c=13.4090(2)Å
α=112.6580(10)° β=103.9430(10)° γ=92.2560(10)°
C11H15N2O4
C11H15N2O4
RSC Advances (2016) 6, 109 107317
a=9.03640(25)Å b=18.7601(5)Å c=7.32887(12)Å
α=90.0° β=105.8400(13)° γ=90.0°
Amodiaquine Dihydrochloride Dihydrate
C20H24ClN3O,2(Cl),2(H2O)
CrystEngComm (2019) 21, 13 2053
a=7.69610(14)Å b=10.9153(2)Å c=27.2368(5)Å
α=90° β=96.1341(7)° γ=90°
4PiNHPI
C19H24N2O2
Physical chemistry chemical physics : PCCP (2018) 20, 23 16033-16044
a=5.26649(14)Å b=10.6373(3)Å c=15.2944(5)Å
α=72.6185(17)° β=89.9112(17)° γ=83.0728(16)°
4PyrNHPI
C18H22N2O2
Physical chemistry chemical physics : PCCP (2018) 20, 23 16033-16044
a=5.1353(2)Å b=10.3387(4)Å c=29.0552(12)Å
α=90° β=92.523(3)° γ=90°
3PiNHPl
C19H24N2O2
Physical chemistry chemical physics : PCCP (2018) 20, 23 16033-16044
a=6.7785(2)Å b=9.8025(3)Å c=25.4462(7)Å
α=90° β=94.7017(18)° γ=90°
3PryNHPI
C18H22N2O2
Physical chemistry chemical physics : PCCP (2018) 20, 23 16033-16044
a=10.7455(9)Å b=26.6113(17)Å c=10.8489(7)Å
α=90° β=99.080(4)° γ=90°
5Me3SAP
C13H12N2O
CrystEngComm (2018) 20, 15 2144
a=14.5415(18)Å b=5.0163(6)Å c=14.8807(18)Å
α=90° β=100.551(2)° γ=90°
5OMe-3SAP
C13H12N2O2
CrystEngComm (2018) 20, 15 2144
a=6.1596(4)Å b=7.4634(4)Å c=12.7106(6)Å
α=77.175(3)° β=81.457(3)° γ=78.821(3)°
5Br3SAP-3,4OHBA
C19H15BrN2O5
CrystEngComm (2018) 20, 15 2144
a=8.5222(14)Å b=10.8771(15)Å c=11.5925(19)Å
α=106.506(6)° β=103.783(4)° γ=112.254(10)°
5Br3SAP-4ClBA
C12H9BrN2O,C7H5ClO2
CrystEngComm (2018) 20, 15 2144
a=33.0322(16)Å b=6.2046(3)Å c=18.5200(8)Å
α=90° β=109.2160(10)° γ=90°
5Br-5M3SAP
C13H11BrN2O
CrystEngComm (2018) 20, 15 2144
a=5.8531(9)Å b=7.5224(12)Å c=13.598(2)Å
α=94.526(7)° β=93.369(7)° γ=99.310(7)°
5Cl-5Me3SAP
C13H11ClN2O
CrystEngComm (2018) 20, 15 2144
a=5.8388(13)Å b=7.4762(17)Å c=13.369(3)Å
α=93.793(7)° β=93.656(7)° γ=99.044(7)°
3Me-5MSAP
C17H20N2O
CrystEngComm (2018) 20, 15 2144
a=6.0801(5)Å b=15.1860(13)Å c=16.4018(14)Å
α=90° β=90° γ=90°
5Br3SAP-BA
(C12H9BrN2O),(C7H6O2)
CrystEngComm (2018) 20, 15 2144
a=32.6081(14)Å b=6.1424(3)Å c=17.8481(8)Å
α=90° β=106.922(3)° γ=90°
35Br-3SAP
C12H8Br2N2O
CrystEngComm (2018) 20, 15 2144
a=14.6532(3)Å b=4.52630(10)Å c=18.6301(4)Å
α=90° β=92.499(2)° γ=90°
35Cl-3SAP
C12H8Cl2N2O
CrystEngComm (2018) 20, 15 2144
a=26.1636(6)Å b=3.80910(10)Å c=34.4455(6)Å
α=90° β=137.4640(10)° γ=90°
5Br3SAP-35OHBA
3(C12H9BrN2O),2(C7H6O4)
CrystEngComm (2018) 20, 15 2144
a=8.2123(2)Å b=12.3360(2)Å c=13.0008(2)Å
α=65.6550(10)° β=78.6480(10)° γ=83.5680(10)°
5Cl3SAP-4ClBA
C12H9ClN2O,C7H5ClO2
CrystEngComm (2018) 20, 15 2144
a=32.818(8)Å b=6.2380(15)Å c=18.465(5)Å
α=90° β=109.440(4)° γ=90°
35Br3SAP-35NO2BA
C12H8Br2N2O,C7H4N2O6
CrystEngComm (2018) 20, 15 2144
a=37.206(3)Å b=7.3594(6)Å c=7.5694(6)Å
α=90° β=91.589(2)° γ=90°
5Br3SAP-14IBz
C12H9BrN2O,0.5(C6H4I2)
CrystEngComm (2018) 20, 15 2144
a=33.7985(6)Å b=6.91740(10)Å c=6.17460(10)Å
α=90° β=92.7900(10)° γ=90°
5Br3SAP-13IBz
C15H11BrIN2O
CrystEngComm (2018) 20, 15 2144
a=6.1651(12)Å b=66.924(13)Å c=6.8330(13)Å
α=90° β=90° γ=90°
35tBu-3SAP
C20H26N2O
CrystEngComm (2018) 20, 15 2144
a=6.1462(6)Å b=18.7572(19)Å c=16.1025(16)Å
α=90° β=95.859(2)° γ=90°
4OH-3SAP
C12H10N2O2
CrystEngComm (2018) 20, 15 2144
a=13.1386(3)Å b=7.1572(2)Å c=11.8627(2)Å
α=90° β=116.8000(10)° γ=90°
3OEt-3SAP
C14H14N2O2
CrystEngComm (2018) 20, 15 2144
a=41.659(5)Å b=24.658(3)Å c=4.8420(6)Å
α=90° β=90° γ=90°
5Br3SAP-14IbiPh
C12H9BrN2O,0.5(I2C12H8)
CrystEngComm (2018) 20, 15 2144
a=37.851(2)Å b=6.9901(4)Å c=6.168(3)Å
α=90° β=90.041(2)° γ=90°
5Br3SAP-2OHBA
(C12H9BrN2O1),(C7H6O3)
CrystEngComm (2018) 20, 15 2144
a=3.82640(10)Å b=20.7111(7)Å c=21.2587(8)Å
α=90° β=93.890(2)° γ=90°
(2-(3',3'-dimethyl-6-nitrospiro[chromene-2,2'-indolin]-1'-yl)ethyl isonicotinate)(2-cyanoethyl)bis(dimethylglyoximato)cobalt(III)
C37H41CoN8O9
CrystEngComm (2018) 20, 39 6061
a=8.4955(14)Å b=27.439(4)Å c=16.401(2)Å
α=90° β=95.394(5)° γ=90°
(2-(3',3'-dimethyl-6-nitrospiro[chromene-2,2'-indolin]-1'-yl)ethyl isonicotinate)(2-cyanoethyl)bis(dimethylglyoximato)cobalt(III)
C37H41CoN8O9
CrystEngComm (2018) 20, 39 6061
a=8.4607(10)Å b=27.278(3)Å c=16.4849(19)Å
α=90° β=95.116(3)° γ=90°
(2-(3',3'-dimethyl-6-nitrospiro[chromene-2,2'-indolin]-1'-yl)ethyl isonicotinate)(2-cyanoethyl)bis(dimethylglyoximato)cobalt(III)
C37H41CoN8O9
CrystEngComm (2018) 20, 39 6061
a=8.2378(7)Å b=16.8515(10)Å c=27.139(2)Å
α=90° β=97.961(5)° γ=90°
(2-(3',3'-dimethyl-6-nitrospiro[chromene-2,2'-indolin]-1'-yl)ethyl isonicotinate)(1-cyanoethyl)bis(dimethylglyoximato)cobalt(III)
C37H41CoN8O9
CrystEngComm (2018) 20, 39 6061
a=8.3729(5)Å b=15.8749(10)Å c=27.9083(16)Å
α=90° β=94.283(4)° γ=90°
Metoclopramide hydrochloride oxalic acid
C14H23ClN3O2,0.5(C2H2O4),Cl
CrystEngComm (2018) 20, 19 2653
a=7.5270(4)Å b=14.1483(9)Å c=34.3682(19)Å
α=90° β=90° γ=90°
Metoclopramide HCl Monohydrate
C14H23ClN3O2,Cl,H2O
CrystEngComm (2018) 20, 19 2653
a=12.1124(17)Å b=8.5524(12)Å c=16.849(3)Å
α=90° β=98.605(7)° γ=90°
Metoclopramide HCl anhydrate
C14H23ClN3O2,Cl
CrystEngComm (2018) 20, 19 2653
a=14.6866(4)Å b=7.0245(2)Å c=33.0316(9)Å
α=90° β=90° γ=90°
C21H21N3O5
C21H21N3O5
CrystEngComm (2019) 21, 20 3170
a=13.7790(3)Å b=6.80670(10)Å c=42.0629(8)Å
α=90° β=97.2200(10)° γ=90°
C21H19N3O4
C21H19N3O4
CrystEngComm (2019) 21, 20 3170
a=7.91100(10)Å b=11.6159(2)Å c=40.0826(7)Å
α=90° β=90° γ=90°
C156H140B12N4O32
C156H140B12N4O32
Chem.Commun. (2014) 50, 13683
a=13.9953(4)Å b=13.9953(4)Å c=104.431(3)Å
α=90° β=90° γ=90°
(C156H140B12N4O32),2(C7H8),0.85(C7H8),0.6(C7H8)
(C156H140B12N4O32),2(C7H8),0.85(C7H8),0.6(C7H8)
Chem.Commun. (2014) 50, 13683
a=25.7426(8)Å b=21.2737(6)Å c=42.0407(11)Å
α=90° β=98.2499(10)° γ=90°
C10H6O8.2(CH4O)
C10H6O8.2(CH4O)
Chemical Communications (2010) 46, 24 4264-4266
a=3.8860(3)Å b=11.0240(9)Å c=15.9140(13)Å
α=89.827(2)° β=88.318(2)° γ=89.997(2)°
From C:/data/powder/koshima_ipbp/irr/rietveld/ipbp_irr_rrr.cif
C31H37NO2
CrystEngComm (2011) 13, 9 3197
a=20.0585(4)Å b=9.71812(17)Å c=13.84077(26)Å
α=90.0° β=90.0° γ=90.0°
C32H24O2
C32H24O2
CrystEngComm (2011) 13, 3 731
a=11.3635(14)Å b=14.1791(17)Å c=15.1146(18)Å
α=90.00° β=111.006(2)° γ=90.00°
C32H24O2
C32H24O2
CrystEngComm (2011) 13, 3 731
a=11.3843(15)Å b=14.2937(19)Å c=15.125(2)Å
α=90.00° β=111.656(3)° γ=90.00°
C32H24O2
C32H24O2
CrystEngComm (2011) 13, 3 731
a=11.3564(14)Å b=14.1618(17)Å c=15.1141(18)Å
α=90.00° β=111.017(2)° γ=90.00°
C36H30AuClP2
C36H30AuClP2
Dalton Transactions (2009) 16 3085-3091
a=10.8650(2)Å b=11.83530(10)Å c=14.2085(2)Å
α=113.3174(10)° β=95.3078(8)° γ=109.5354(9)°
C36H30AuClP2
C36H30AuClP2
Dalton Transactions (2009) 16 3085-3091
a=10.8219(3)Å b=11.8053(2)Å c=14.1589(3)Å
α=113.2433(14)° β=95.5275(12)° γ=109.5034(13)°
C36H30AuClP2
C36H30AuClP2
Dalton Transactions (2009) 16 3085-3091
a=10.8666(2)Å b=11.83540(10)Å c=14.1974(2)Å
α=113.1999(9)° β=95.3789(8)° γ=109.5993(8)°
C36H30AuClP2
C36H30AuClP2
Dalton Transactions (2009) 16 3085-3091
a=10.8463(2)Å b=11.8202(2)Å c=14.1697(3)Å
α=113.1231(12)° β=95.5306(10)° γ=109.5776(11)°
C36H30AuClP2
C36H30AuClP2
Dalton Transactions (2009) 16 3085-3091
a=10.8497(2)Å b=11.8235(2)Å c=14.1665(2)Å
α=113.0306(11)° β=95.5779(9)° γ=109.6278(10)°
C36H30AuClP2
C36H30AuClP2
Dalton Transactions (2009) 16 3085-3091
a=10.8546(2)Å b=11.82870(10)Å c=14.1760(2)Å
α=113.0546(10)° β=95.5288(8)° γ=109.6372(9)°
C36H30AuClP2
C36H30AuClP2
Dalton Transactions (2009) 16 3085-3091
a=10.8346(2)Å b=11.82020(10)Å c=14.1569(2)Å
α=112.9509(10)° β=95.6325(8)° γ=109.6808(9)°
C36H30AuClP2
C36H30AuClP2
Dalton Transactions (2009) 16 3085-3091
a=10.8864(2)Å b=11.84780(10)Å c=14.2488(2)Å
α=113.6079(10)° β=95.0211(8)° γ=109.4016(9)°
C36H30AuClP2
C36H30AuClP2
Dalton Transactions (2009) 16 3085-3091
a=10.8751(2)Å b=11.8388(2)Å c=14.2303(3)Å
α=113.5728(12)° β=95.1053(10)° γ=109.3924(11)°
Epalerstat. DMF solvate
C15H13NO3S2,C3H7NO
CrystEngComm (2017)
a=7.6999(3)Å b=8.7601(3)Å c=15.1662(5)Å
α=102.148(7)° β=95.754(7)° γ=110.011(8)°
2-[(5Z)-5-[(E)-2-methyl-3-phenylprop-2-enylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]
C8H10N4O2,C15H13NO3S2
CrystEngComm (2017)
a=7.7900(4)Å b=8.4073(4)Å c=19.8594(10)Å
α=84.159(3)° β=88.907(2)° γ=62.877(3)°
Epalerstat. 2 DMSO
C15H13NO3S2,2(C2H6OS)
CrystEngComm (2017)
a=8.0773(2)Å b=9.3224(2)Å c=16.0729(3)Å
α=99.322(7)° β=91.404(6)° γ=108.099(8)°
Ciprofloxacin Hydrochloride Anhydrous Form II
C17H19FN3O3,Cl
CrystEngComm (2020)
a=12.4523(2)Å b=6.91819(13)Å c=19.4137(4)Å
α=90° β=101.2940(9)° γ=90°
5Br3SAP-35OHBA
C19H13BrCl2N2O3
CrystEngComm (2018) 20, 15 2144
a=34.7332(18)Å b=3.8928(2)Å c=28.2337(15)Å
α=90° β=99.982(2)° γ=90°
2-(3',3'-dimethyl-6-nitrospiro[chromene-2,2'-indolin]-1'-yl)ethyl isonicotinate
C26H23N3O5
CrystEngComm (2018) 20, 39 6061
a=22.4072(6)Å b=8.3342(3)Å c=12.0143(4)Å
α=90° β=90.452(2)° γ=90°
C36H30AuClP2
C36H30AuClP2
Dalton Transactions (2009) 16 3085-3091
a=10.8426(2)Å b=11.82480(10)Å c=14.1569(2)Å
α=112.9509(10)° β=95.6325(8)° γ=109.6808(9)°
C31H44CoN7O5,CH4O
C31H44CoN7O5,CH4O
CrystEngComm (2016) 18, 38 7330
a=9.2160(3)Å b=26.7430(10)Å c=13.9320(5)Å
α=90.00° β=96.9100(10)° γ=90.00°
C31H44CoN7O5,CH4O
C31H44CoN7O5,CH4O
CrystEngComm (2016) 18, 38 7330
a=9.1680(6)Å b=26.964(2)Å c=14.0240(11)Å
α=90.00° β=97.328(2)° γ=90.00°
C24H30CoN7O6
C24H30CoN7O6
CrystEngComm (2016) 18, 38 7330
a=17.2110(5)Å b=7.5620(2)Å c=21.4770(5)Å
α=90.00° β=107.5550(10)° γ=90.00°
C31H44CoN7O5
C31H44CoN7O5
CrystEngComm (2016) 18, 38 7330
a=8.9000(8)Å b=12.2160(12)Å c=16.8180(15)Å
α=109.239(3)° β=94.666(3)° γ=104.585(3)°